E-mail: Jaafar.Bennouna@univ-nates.fr
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- CONTINUATION OF BEVACIZUMAB AFTER FIRST PROGRESSION IN METASTATIC COLORECTAL CANCER (ML18147): A RANDOMISED PHASE 3 TRIAL
- MLN8237 (ALISERTIB), AN INVESTIGATIONAL AURORA A KINASE INHIBITOR, IN PATIENTS (PTS) WITH NON-SMALL CELL LUNG CANCER (NSCLC), SMALL CELL LUNG CANCER (SCLC), BREAST CANCER (BRC), HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC), AND GASTROESOPHAGEAL CANC
- Phase (Ph) I/II study of investigational Aurora A kinase (AAK) inhibitor MLN8237 (alisertib): Updated ph II results in patients (pts) with small cell lung cancer (SCLC), non-SCLC (NSCLC), breast cancer (BrC), head and neck squamous cell carcinoma (HN
- Phase I/II study of the investigational aurora A kinase (AAK) inhibitor MLN8237 (alisertib) in patients (pts) with non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), breast cancer (BrC), head/neck cancer (H&N), and gastroesophageal (G
- Prospective randomised phase II trial of oral vinorelbine (NVBo) and cisplatin (P) or pemetrexed (Pem) and P in first-line metastatic or locally advanced non-small cell lung cancer (M or LA NSCLC) with nonsquamous (Non SCC) histological type. NAVoTRI
- Prospective randomized phase II trial of oral vinorelbine (NVBo) and cisplatin (P) or pemetrexed (Pem) and P in first-line metastatic or locally advanced non-small cell lung cancer (M or LA NSCLC) patients (pts) with nonsquamous (non SCC) histologic
- RANDOMISED PHASE II TRIAL OF ORAL VINORELBINE (N) AND CISPLATIN (P) OR PEMETREXED AND C (PC) IN FIRST LINE ADVANCED NON SQUAMOUS (NSCC) NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS). NAVOTRIAL01: FINAL RESULTS
